SToP Cancer SPORE: Administrative Core A
STOP Cancer SPORE:行政核心 A
基本信息
- 批准号:10334082
- 负责人:
- 金额:$ 15.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-16 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:AdvocacyAdvocateBasic ScienceClinicalClinical TrialsCollaborationsCommunicationConsultationsDataDevelopmentDiseaseDisputesElementsEnsureEvaluationFacultyFoundationsFund RaisingFundingGrantHuman Subject ResearchInfrastructureInternationalLeadershipMalignant neoplasm of pancreasMentorshipMinorityMonitorNational Cancer InstituteOccupational activity of managing financesPatientsPilot ProjectsPopulationPrivatizationProgram EvaluationProgram Research Project GrantsPublicationsRegulationReportingResearchResearch PersonnelResearch PriorityResearch Project GrantsResourcesSeriesStrategic PlanningTalentsTimeTimeLineTranslational ResearchUnited States National Institutes of HealthUniversitiesWorkanticancer researchcancer carecareercareer developmentcost effectivemeetingsnew technologyoperationoutreachprogramsrecruittranslational cancer researchtranslational scientistwebsite development
项目摘要
CORE A: ABSTRACT
The Administrative Core (Core A) supports the work of this SToP Cancer SPORE. The Administrative Core and
its leadership team led by Dr. Yeh will be responsible for strategic planning, management and commitment of all
project and core resources, and ensuring compliance with all university, federal, and specific NCI/NIH grant
regulations and requirements, including timely communications and consultations with the National Cancer
Institute. Core A will oversee and facilitate all interactions with SPORE investigators and collaborators external
to UNC Lineberger. Additionally, Core A will coordinate all necessary meetings to administer the programmatic
operation of the SPORE, including meetings of the Executive Steering Committee, Internal Advisory Board,
External Advisory Board, and SToP Cancer SPORE investigators. Through this series of meetings, the Core
assumes responsibility for scientific oversight of the SPORE and will also oversee the activities of the
Developmental Research and Career Enhancement Programs. These functions will assist the SPORE
leadership in ongoing planning and evaluation of the program to ensure progress towards the accomplishment
of the proposed aims and resolve scientific disputes that arise. Core A will coordinate all human subject research-
related activities for compliance with institutional and federal regulatory requirements. In addition, Core A will
have overall fiscal responsibility for the SPORE to ensure cost-effective and efficient use of resources, including
the substantial institutional commitment to projects, infrastructure and recruitment allocated to leadership,
which approaches $7.5M over the 5 years of the SPORE.
Through these activities, the UNC SToP Cancer SPORE Administrative Core supports an exceptional team of
pancreatic cancer translational researchers as they seek to understand this deadly disease and its treatment,
advance new technology, and develop junior faculty into translational research leaders.
核心 A:摘要
行政核心(核心 A)支持该 STOP Cancer SPORE 的工作。行政核心和
由叶博士领导的领导团队将负责战略规划、管理和承诺
项目和核心资源,并确保遵守所有大学、联邦和特定 NCI/NIH 拨款
法规和要求,包括与国家癌症中心及时沟通和协商
研究所。核心 A 将监督并促进与 SPORE 调查人员和外部合作者的所有互动
北卡罗来纳大学莱恩伯格分校。此外,核心 A 将协调所有必要的会议来管理计划
SPORE 的运作,包括执行指导委员会、内部顾问委员会的会议,
外部咨询委员会和 STOP Cancer SPORE 调查员。通过这一系列的会议,核心
负责 SPORE 的科学监督,并将监督 SPORE 的活动
发展研究和职业提升计划。这些功能将协助 SPORE
领导该方案的持续规划和评估,以确保在实现目标方面取得进展
拟议的目标并解决出现的科学争议。核心A将协调所有人类课题研究——
遵守机构和联邦监管要求的相关活动。此外,核心A将
对 SPORE 负有全面的财政责任,以确保资源的成本效益和高效利用,包括
对分配给领导层的项目、基础设施和招聘的大量机构承诺,
SPORE 的 5 年成本接近 750 万美元。
通过这些活动,北卡罗来纳大学 STOP Cancer SPORE 行政核心支持一支由以下人员组成的杰出团队:
胰腺癌转化研究人员在寻求了解这种致命疾病及其治疗方法时,
推进新技术,并将初级教师培养成转化研究领导者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jen Jen Yeh其他文献
Jen Jen Yeh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jen Jen Yeh', 18)}}的其他基金
Project 3: Transcriptomic subtypes, response predictions, and therapy selection
项目 3:转录组亚型、反应预测和治疗选择
- 批准号:
10845920 - 财政年份:2023
- 资助金额:
$ 15.85万 - 项目类别:
Project 3: Transcriptomic subtypes, response predictions, and therapy selection
项目 3:转录组亚型、反应预测和治疗选择
- 批准号:
10334085 - 财政年份:2022
- 资助金额:
$ 15.85万 - 项目类别:
SToP Cancer SPORE: Administrative Core A
STOP Cancer SPORE:行政核心 A
- 批准号:
10705565 - 财政年份:2022
- 资助金额:
$ 15.85万 - 项目类别:
Role of cingulin in FOLFIRINOX resistance
cingulin 在 FOLFIRINOX 耐药中的作用
- 批准号:
10816835 - 财政年份:2022
- 资助金额:
$ 15.85万 - 项目类别:
Project 3: Transcriptomic subtypes, response predictions, and therapy selection
项目 3:转录组亚型、反应预测和治疗选择
- 批准号:
10705586 - 财政年份:2022
- 资助金额:
$ 15.85万 - 项目类别:
Project 3: Transcriptomic subtypes, therapy selection and response
项目 3:转录组亚型、治疗选择和反应
- 批准号:
10912977 - 财政年份:2022
- 资助金额:
$ 15.85万 - 项目类别:
Targeting Ras-Ral GEF-Ral Effector Signaling for Pancreatic Cancer Treatment
靶向 Ras-Ral GEF-Ral 效应信号传导用于胰腺癌治疗
- 批准号:
8433261 - 财政年份:2010
- 资助金额:
$ 15.85万 - 项目类别:
相似海外基金
The Cholangiocarcinoma Conference: Molecular Drivers, Microenvironment, and Precision Medicine
胆管癌会议:分子驱动因素、微环境和精准医学
- 批准号:
10747566 - 财政年份:2023
- 资助金额:
$ 15.85万 - 项目类别:
Evaluation of Cancer Health Activism Network for Greater Equity (CHANGE)
癌症健康行动网络的评估以实现更大的公平(变更)
- 批准号:
10665478 - 财政年份:2023
- 资助金额:
$ 15.85万 - 项目类别:
SToP Cancer SPORE: Administrative Core A
STOP Cancer SPORE:行政核心 A
- 批准号:
10705565 - 财政年份:2022
- 资助金额:
$ 15.85万 - 项目类别: